POST Online Media Lite Edition


Priya Agrawal named managing director for MSD, South Africa and Sub-Saharan Africa cluster

Christian Fernsby |
Johannesburg, South Africa - MSD, known as Merck & Co., Inc., in the United States and Canada, announces the appointment of Priya Agrawal as managing director for the South Africa and Sub-Saharan Africa cluster.

Dr Agrawal trained as an Obstetrician and Gynaecologist in the United Kingdom.

After receiving her degrees in Medicine from the University of Cambridge and University of Oxford, she graduated with a master’s degree from the Harvard School of Public Health on a Fulbright Scholarship.

In her most recent role, Dr Agrawal was Executive Director for Vaccines and Women’s Health in MSD’s UK subsidiary.

Dr Agrawal previously served as Executive Director of MSD for Mothers, where she launched and led the global initiative for the company for four years.

Dr Agrawal brings a wealth of public health experience with a strong track record for advancing successful public health initiatives within both the private and public sectors.

She has worked and travelled in more than 45 countries using the introduction of sustainable innovations to improve the health outcomes for underserved women and their families.

Immediately prior to joining MSD, she served as Director of Research and Innovation for the Women and Health Initiative at the Harvard School of Public Health where she led the development and evaluation of healthcare innovations.

She has contributed to various international technical committees and advisory councils for the World Health Organization and Bill and Melinda Gates Foundation-funded initiatives.

She is a fellow of the Royal Society of Medicine.


Investec Property Fund appoints Zaida Adams as CFO
Accentuate appoints Wisdom Mushohwe as permanent CFO
Vodacom appoints two directors
African Bank appoints two independent nonexecutive directors
Andre de Ruyter appointed as Eskom CEO